Novoseven 1 mg Injection belongs to the class of antihemophilic medicine. It is primarily used to prevent excessive bleeding after surgery or other important treatments, especially in patients with congenital hemophilia who do not respond to factor VIII or IX treatment, acquired hemophilia, factor VII deficiency, and Glanzmann’s thrombosthenia.
Novoseven 1 mg Injection contains Eptacog alfa (activated), which is an antihemophilic drug. It helps clot the bleeding when our body’s clotting factors do not respond.
Novoseven 1 mg Injection may cause certain side effects such as headache, nausea, vomiting, fatigue, fever, flushing (sense of warmth) of the face, fast or irregular heart rate, low blood pressure, and redness, pain, or swelling at the injection site. These side effects may not occur in everyone using this medication and gradually resolve over time. Novoseven 1 mg Injection will be administered by a trained healthcare doctor.
Before starting Novoseven 1 mg Injection, inform your doctor if you have any allergies to the components present in it. Let your doctor know about your complete medical and medication history to rule out any serious adverse effects. Inform your doctor, if you have any history of liver or kidney disease, a recent history of surgery or crush injury, atherosclerosis, or bleeding disorder. Pregnant and breastfeeding women should consult their doctor before using Novoseven 1 mg Injection.